These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 25931201)

  • 21. The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.
    Lima VA; Esquinelato R; Carmo-Gonçalves P; Nascimento LAD; Lee H; Eliezer D; Romão L; Follmer C
    FEBS Lett; 2022 Feb; 596(3):309-322. PubMed ID: 34928512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translocation of Distinct Alpha Synuclein Species from the Nucleus to Neuronal Processes during Neuronal Differentiation.
    Pieger K; Schmitt V; Gauer C; Gießl N; Prots I; Winner B; Winkler J; Brandstätter JH; Xiang W
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.
    Villar-Piqué A; Lopes da Fonseca T; Sant'Anna R; Szegö ÉM; Fonseca-Ornelas L; Pinho R; Carija A; Gerhardt E; Masaracchia C; Abad Gonzalez E; Rossetti G; Carloni P; Fernández CO; Foguel D; Milosevic I; Zweckstetter M; Ventura S; Outeiro TF
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6506-E6515. PubMed ID: 27708160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal acetylation mutants affect alpha-synuclein stability, protein levels and neuronal toxicity.
    Vinueza-Gavilanes R; Íñigo-Marco I; Larrea L; Lasa M; Carte B; Santamaría E; Fernández-Irigoyen J; Bugallo R; Aragón T; Aldabe R; Arrasate M
    Neurobiol Dis; 2020 Apr; 137():104781. PubMed ID: 31991248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E46K α-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation.
    Íñigo-Marco I; Valencia M; Larrea L; Bugallo R; Martínez-Goikoetxea M; Zuriguel I; Arrasate M
    Proc Natl Acad Sci U S A; 2017 Sep; 114(39):E8274-E8283. PubMed ID: 28900007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective role of olesoxime against wild-type α-synuclein-induced toxicity in human neuronally differentiated SHSY-5Y cells.
    Gouarné C; Tracz J; Paoli MG; Deluca V; Seimandi M; Tardif G; Xilouri M; Stefanis L; Bordet T; Pruss RM
    Br J Pharmacol; 2015 Jan; 172(1):235-45. PubMed ID: 25220617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligomers of Parkinson's Disease-Related α-Synuclein Mutants Have Similar Structures but Distinctive Membrane Permeabilization Properties.
    Stefanovic AN; Lindhoud S; Semerdzhiev SA; Claessens MM; Subramaniam V
    Biochemistry; 2015 May; 54(20):3142-50. PubMed ID: 25909158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxic effects of human and rodent variants of alpha-synuclein in vivo.
    Landeck N; Buck K; Kirik D
    Eur J Neurosci; 2017 Feb; 45(4):536-547. PubMed ID: 27893183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-synuclein deregulates the expression of COL4A2 and impairs ER-Golgi function.
    Paiva I; Jain G; Lázaro DF; Jerčić KG; Hentrich T; Kerimoglu C; Pinho R; Szegő ÈM; Burkhardt S; Capece V; Halder R; Islam R; Xylaki M; Caldi Gomes LA; Roser AE; Lingor P; Schulze-Hentrich JM; Borovečki F; Fischer A; Outeiro TF
    Neurobiol Dis; 2018 Nov; 119():121-135. PubMed ID: 30092270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss in Toxic Function of Aggregates of α -Synuclein Mutants by a β-Synuclein Derived Peptide.
    Mohammadi S; Nikkhah M; Hosseinkhani S
    Protein Pept Lett; 2017; 24(8):757-764. PubMed ID: 28820063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity.
    Luna E; Decker SC; Riddle DM; Caputo A; Zhang B; Cole T; Caswell C; Xie SX; Lee VMY; Luk KC
    Acta Neuropathol; 2018 Jun; 135(6):855-875. PubMed ID: 29502200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formation of large oligomers of DOPAL-modified α-synuclein is modulated by the oxidation of methionine residues located at C-terminal domain.
    Coelho-Cerqueira E; de Araújo Correia Campos C; Follmer C
    Biochem Biophys Res Commun; 2019 Feb; 509(2):367-372. PubMed ID: 30591215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane binding, internalization, and sorting of alpha-synuclein in the cell.
    Masaracchia C; Hnida M; Gerhardt E; Lopes da Fonseca T; Villar-Pique A; Branco T; Stahlberg MA; Dean C; Fernández CO; Milosevic I; Outeiro TF
    Acta Neuropathol Commun; 2018 Aug; 6(1):79. PubMed ID: 30107856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
    Dulovic M; Jovanovic M; Xilouri M; Stefanis L; Harhaji-Trajkovic L; Kravic-Stevovic T; Paunovic V; Ardah MT; El-Agnaf OM; Kostic V; Markovic I; Trajkovic V
    Neurobiol Dis; 2014 Mar; 63():1-11. PubMed ID: 24269733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
    Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extracellular aggregated alpha synuclein primarily triggers lysosomal dysfunction in neural cells prevented by trehalose.
    Hoffmann AC; Minakaki G; Menges S; Salvi R; Savitskiy S; Kazman A; Vicente Miranda H; Mielenz D; Klucken J; Winkler J; Xiang W
    Sci Rep; 2019 Jan; 9(1):544. PubMed ID: 30679445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of alpha-synuclein at non-toxic levels increases dopaminergic cell death induced by copper exposure via modulation of protein degradation pathways.
    Anandhan A; Rodriguez-Rocha H; Bohovych I; Griggs AM; Zavala-Flores L; Reyes-Reyes EM; Seravalli J; Stanciu LA; Lee J; Rochet JC; Khalimonchuk O; Franco R
    Neurobiol Dis; 2015 Sep; 81():76-92. PubMed ID: 25497688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A30P mutant α-synuclein impairs autophagic flux by inactivating JNK signaling to enhance ZKSCAN3 activity in midbrain dopaminergic neurons.
    Lei Z; Cao G; Wei G
    Cell Death Dis; 2019 Feb; 10(2):133. PubMed ID: 30755581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of prolyl oligopeptidase increases the survival of alpha-synuclein overexpressing cells after rotenone exposure by reducing alpha-synuclein oligomers.
    Dokleja L; Hannula MJ; Myöhänen TT
    Neurosci Lett; 2014 Nov; 583():37-42. PubMed ID: 25240592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.